The Global Peripherally Inserted Central Catheters (PICC) market is set to progress at a compound annual growth rate of over 5%. With growing demand, integration of advanced technologies, and new product launches by leading players in the market, it is expected to reach 1.1 billion USD by 2026.
The increase in market size is due to growing demand for PICC’s. Infectious diseases and rising rate of cancer are some key factors driving this demand. PICC’s are used to administer drugs directly into the veins and avoid irritation in the veins. They are also often used for parental nutrition for those suffering from a variety of conditions that impair food intake, nutrient digestion, or absorption.
With the presence of enhanced and advanced healthcare facilities, North America is anticipated to dominate the global Peripherally Inserted Central Catheters market during the forecast period, behind its leading PICC companies including Health Line International. The success rate of PICC placement is high and the complication rate is low. North America also has well-established guidelines for PICC use in the region, giving them an edge against other countries.
Here at Health Line International Corp., we manufacturer and distribute high-quality PICC’s from our facility in Utah. Health Line’s power PICC lines are designed with both function and patient comfort in mind. Our standard PICC line kits come in a variety of configurations to provide nurses, doctors, radiologists, and other healthcare professionals the tools they need to safely administer intravenous therapies and deliver exceptional care to patients of all ages.
Health Line International Corp. is not responsible for any errors, omissions, injury, loss, or damage arising from or relating to the use (or misuse) of any information, statements, or conclusions contained in or implied by the contents of this document or any of the source materials. This content is not intended to replace professional medical advice.